MIR4266

Across TCGA pan-cancer cohorts, MIR4266 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR4266 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR4266 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4266 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

OV, HNSC, and KIRC are the cancer types where MIR4266 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.344	0.546	.003	90	view →
HNSC	DFS	Tertile	All	0.148	0.628	.001	72	view →
KIRC	DFS	Tertile	IV	0.090	0.641	<.001	48	view →
BRCA	OS	Tertile	II,III,IV	0.592	0.913	.004	42	view →
LUSC	OS	Tertile	II,III,IV	0.100	0.780	<.001	36	view →
GBM	OS	Tertile	All	0.159	0.420	<.001	27	view →
ESCA	DFS	Tertile	All	1.000	0.299	.008	24	view →
SKCM	DFS	Tertile	II,III,IV	0.170	0.682	.016	18	view →
LIHC	DFS	Tertile	All	0.097	0.543	.033	18	view →
UCEC	OS	Tertile	All	0.619	0.874	.021	18	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR4266–OV (DFS)

Open the OV breakdown →